MedTrace Logo

Evaluation of the Optimal Transition Program

NCT04263233 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-09-22

No results posted yet for this study

Summary

This is an evaluation of a program developed by a team of nephrologists, operations experts and researchers. The goal is to provide CKD patients with a better way to transition to life on dialysis - one that emphasizes even more individual clinical, psychosocial and lifestyle needs. On top of high-quality clinical care, the 4-week Optimal Transition program supports patients as they adjust to treatment and learn to live the best life possible. This is done through a robust education curriculum and a trust-building approach.

Conditions

  • ESRD
  • Hemodialysis

Interventions

OTHER

Analysis using descriptive statistics of patient clinical outcomes.

Evaluation of the following: * Laboratory values at admission, week 4, and day 90. * Pre and post blood pressure at week one and week 4. * Intradialytic hypotension at week one and week 4. * Ultrafiltration rates at week one, week 4, day 90, day 180, and day 360. * Target weight defined and achievement in week one and week 4 and changes between week one and week 4. * Dialysis access type at week one and day 90. * Hospitalization and mortality rates.

OTHER

Surveys with participants using validated survey tools.

Surveys will assess participants' Symptom index, Quality of Life, Patient Activation as well as satisfaction with the program.

OTHER

Evaluation of the program process including time, costs, referral rates, admission to the program and length of stay.

Data will be collected using tracking tools throughout the program.

Sponsors & Collaborators

  • Satellite Healthcare

    lead OTHER

Principal Investigators

  • Wael F Hussein, MBBS · Satellite Healthcare, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-29
Primary Completion
2022-07-28
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04263233 on ClinicalTrials.gov